Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 4,903 shares at $34.17 ($168K) on 2025-03-19, disclosed to the SEC on 2025-03-21.
Scheduled sale ($168k) by Chief Med and Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.17 | 2,388 | $82K | 48.7% |
| 2 | $34.17 | 2,388 | $82K | 48.7% |
| 3 | $34.83 | 127 | $4K | 2.6% |
| Total | $34.19 avg | 4,903 | $168K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |